Report on stage III Pig-a mutation assays using benzo[a]pyrene

Area of Science:

• Toxicology
• Genetics
• Biomedical Research

Background:

• The Pig-a gene mutation assay is crucial for assessing genotoxicity.
• Validation studies are essential for establishing the reliability of toxicological assays.
• Benzo[a]pyrene (BaP) is a known mutagen used as a positive control in genotoxicity testing.

Purpose of the Study:

• To validate the Pig-a gene mutation assay in rats as part of a multi-laboratory study.
• To assess the dose- and time-dependent effects of BaP on Pig-a mutant frequencies.
• To evaluate the assay's reproducibility and transferability across different laboratories and rat strains.

Main Methods:

• Rats (Fischer 344 and Han Wistar) were administered daily doses of BaP for 28 days.
• Pig-a mutant frequencies in red blood cells (RBCs) and reticulocytes (RETs) were measured.
• Micronucleated reticulocyte (%MN-RET) frequencies were also determined.
• Hprt gene mutation assays were performed on splenocytes for comparison.

Main Results:

• BaP treatment led to dose- and time-dependent increases in RBC(CD59-) and RET(CD59-) frequencies in both rat models.
• Responses were stronger in reticulocytes compared to red blood cells and in Fischer 344 rats compared to Han Wistar rats.
• Significant increases in %MN-RET were observed, with greater responses in Fischer 344 rats.
• Hprt gene mutation frequencies were higher than Pig-a gene mutation frequencies.

Conclusions:

• The Pig-a RET and RBC assays are reproducible and transferable, showing promise for genotoxicity testing.
• The assay can be integrated into 28-day repeat-dose toxicity studies.
• The findings support the utility of the Pig-a assay for detecting gene mutations induced by genotoxic substances.